Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Multicenter Trial of Fluconazole Oral Suspension in the Treatment of Esophageal Candidiasis in Immunocompromised Patients

NCT00002339 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00002339
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00002339 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Multicenter Trial of Fluconazole Oral Suspension in the Treatment of Esophageal Candidiasis in Immunocompromised Patients
Lead sponsor
Pfizer
Phase
Phase 3
Overall status
Completed
Start date
Not reported
Completion date
Not reported
Enrollment
100
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

candidiasis, esophageal, hiv infections